204 related articles for article (PubMed ID: 32745879)
21. Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy.
de Carvalho Melo-Cavalcante AA; da Rocha Sousa L; Alencar MVOB; de Oliveira Santos JV; da Mata AMO; Paz MFCJ; de Carvalho RM; Nunes NMF; Islam MT; Mendes AN; Gonçalves JCR; da Silva FCC; Ferreira PMP; de Castro E Sousaa JM
Biomed Pharmacother; 2019 Jan; 109():1394-1405. PubMed ID: 30551390
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory action of antioxidants (ascorbic acid or alpha-tocopherol) on seizures and brain damage induced by pilocarpine in rats.
Tomé Ada R; Ferreira PM; Freitas RM
Arq Neuropsiquiatr; 2010 Jun; 68(3):355-61. PubMed ID: 20602035
[TBL] [Abstract][Full Text] [Related]
23. Brazilin Treatment Produces Antidepressant- and Anxiolytic-Like Effects in Mice.
Wang X; Xiu Z; Du Y; Li Y; Yang J; Gao Y; Li F; Yin X; Shi H
Biol Pharm Bull; 2019; 42(8):1268-1274. PubMed ID: 31366864
[TBL] [Abstract][Full Text] [Related]
24. Developmental lead (Pb)-induced deficits in redox and bioenergetic status of cerebellar synapses are ameliorated by ascorbate supplementation.
Ahmad F; Haque S; Ravinayagam V; Ahmad A; Kamli MR; Barreto GE; Ghulam Md Ashraf
Toxicology; 2020 Jul; 440():152492. PubMed ID: 32407874
[TBL] [Abstract][Full Text] [Related]
25. Anxiolytic effects of ascorbic acid and ketamine in mice.
Fraga DB; Olescowicz G; Moretti M; Siteneski A; Tavares MK; Azevedo D; Colla ARS; Rodrigues ALS
J Psychiatr Res; 2018 May; 100():16-23. PubMed ID: 29475017
[TBL] [Abstract][Full Text] [Related]
26. Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice.
Du Y; Li W; Li Y; Yang J; Wang X; Yin S; Wang X; Velez de-la-Paz OI; Gao Y; Chen H; Yin X; Shi H
Brain Res Bull; 2019 Mar; 146():79-86. PubMed ID: 30597190
[TBL] [Abstract][Full Text] [Related]
27. Association of Depression, Anxiety, and Trauma With Cannabis Use During Pregnancy.
Young-Wolff KC; Sarovar V; Tucker LY; Goler NC; Alexeeff SE; Ridout KK; Avalos LA
JAMA Netw Open; 2020 Feb; 3(2):e1921333. PubMed ID: 32074285
[No Abstract] [Full Text] [Related]
28. Learned Immobility Produces Enduring Impairment of the HPA Axis Reactivity in Mice without Replicating the Broad Spectrum of Depressive-Like Phenotype.
Bullich S; Delcourte S; Haddjeri N; Guiard BP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477830
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
30. The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.
Pereira MM; de Morais H; Dos Santos Silva E; Corso CR; Adami ER; Carlos RM; Acco A; Zanoveli JM
Metab Brain Dis; 2018 Oct; 33(5):1573-1584. PubMed ID: 29934859
[TBL] [Abstract][Full Text] [Related]
31. [Adaptogenic and neuroprotective effects of lithium ascorbate].
Pronin AV; Gromova OA; Sardaryan IS; Torshin IY; Stel'mashuk EV; Ostrenko KS; Aleksandrova OP; Genrikhs EE; Khaspekov LG
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):86-91. PubMed ID: 28139631
[TBL] [Abstract][Full Text] [Related]
32. Perspectives About Ascorbic Acid to Treat Inflammatory Bowel Diseases.
Andriolo IRL; Venzon L; da Silva LM
Drug Res (Stuttg); 2024 Apr; 74(4):149-155. PubMed ID: 38467159
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin in health and disease with a focus on affective disorders.
Zelena D
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):286-303. PubMed ID: 22954353
[TBL] [Abstract][Full Text] [Related]
34. Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels.
Chen WT; Lin YF; Yu FC; Kao WY; Huang WH; Yan HC
Am J Kidney Dis; 2003 Jul; 42(1):158-66. PubMed ID: 12830468
[TBL] [Abstract][Full Text] [Related]
35. Functional role of ascorbic acid in the central nervous system: a focus on neurogenic and synaptogenic processes.
Moretti M; Rodrigues ALS
Nutr Neurosci; 2022 Nov; 25(11):2431-2441. PubMed ID: 34493165
[TBL] [Abstract][Full Text] [Related]
36. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.
Kaufmann FN; Gazal M; Bastos CR; Kaster MP; Ghisleni G
Eur J Pharmacol; 2016 Aug; 784():192-8. PubMed ID: 27235294
[TBL] [Abstract][Full Text] [Related]
37. Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management.
Torta R; Pennazio F; Ieraci V
Reumatismo; 2014 Jun; 66(1):92-7. PubMed ID: 24938201
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Lykkesfeldt J
Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
[TBL] [Abstract][Full Text] [Related]
39. The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders.
Kehne JH
CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):163-82. PubMed ID: 17511614
[TBL] [Abstract][Full Text] [Related]
40. A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice.
Fraga DB; Camargo A; Olescowicz G; Azevedo Padilha D; Mina F; Budni J; Brocardo PS; Rodrigues ALS
Chem Biol Interact; 2021 Jun; 342():109476. PubMed ID: 33872575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]